NEW YORK, July 31, 2019 /PRNewswire/ — Beginning operations for a new clinical site can be a challenge to get up and running. Following the initial launch. First-time clinical sites need to lean on some reliable resources when they’re just getting started, and what better resource to reach out than those most versed with clinical trials and the industry around them? fishbat has compiled a list of the 3 major reasons why first-time clinical sites should utilize patient recruitment in clinical trials to build up their patient pipeline. Keep reading to see how these recruitment sites can benefit your new clinical venture.
While building a patient pipeline for a first-time clinical trial site can seem like a challenge, with the right resources, you’ll get your foot into the clinical trial industry swiftly. For these reasons and more, the best resource for your clinical site is a professional clinical trial recruitment site.
About fishbat
fishbat is a full-service digital marketing firm specializing in clinical trial advertising. The fishbat team takes a holistic business approach to their clients’ digital marketing programs but understanding the importance of business principles just as well as the nuances of the latest digital technologies. fishbat offers every digital marketing service available from digital marketing research and planning to clinical trial brand development to website and asset creation through social media management and search engine optimization programs – all custom calibrated for both B2B and B2C businesses.
View original content:http://www.prnewswire.com/news-releases/fishbat-shares-3-reasons-why-first-time-clinical-sites-should-utilize-clinical-trial-recruitment-companies-to-build-their-patient-pipeline-300887565.html
SOURCE fishbat
Toronto, Ontario--(Newsfile Corp. - March 25, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink:…
Bill Increases Funding for Alzheimer’s Research and Prevention EffortsWASHINGTON, March 23, 2024 (GLOBE NEWSWIRE) --…
The first safe therapy with Dr Allen's Device has once again proved its ability to…
Vancouver, British Columbia--(Newsfile Corp. - March 22, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products,…
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt…